ArriVent BioPharma, Inc. Common Stock Balance Sheet
Concept
Total Assets
Current Assets
Cash, Cash Equivalents & Short Term Investments
Cash & Equivalents
Other Short Term Investments
Receivables
Inventory
Other Current Assets
Total non-current assets
Property, Plant & Equipment
Long-Term Investments
Total Liabilities
Current Liabilities
Accounts Payable
Current Debt
Deferred Revenue
Total Non Current Liabilities Net Minority Interest
Long-Term Debt
Other Long-Term Liabilities
Common Stock Equity
Working Capital
Invested Capital
Total Debt
Net Debt
2022
2021
183M
183M
0M
0M
0M
0M
0M
18M
0M
0M
0M
268M
8M
3M
0M
0M
260M
0M
0M
-85M
174M
-85M
0M
0M
43M
43M
0M
0M
0M
0M
0M
5M
0M
0M
0M
2M
2M
0M
0M
0M
0M
0M
0M
41M
41M
-49M
0M
0M
Concept
Total Assets
Current Assets
Cash, Cash Equivalents & Short Term Investments
Cash & Equivalents
Other Short Term Investments
Receivables
Inventory
Other Current Assets
Total non-current assets
Property, Plant & Equipment
Long-Term Investments
Total Liabilities
Current Liabilities
Accounts Payable
Current Debt
Deferred Revenue
Total Non Current Liabilities Net Minority Interest
Long-Term Debt
Other Long-Term Liabilities
Common Stock Equity
Working Capital
Invested Capital
Total Debt
Net Debt
3Q2023
2Q2023
4Q2022
182M
180M
0M
0M
25M
0M
0M
12M
2M
0M
0M
315M
10M
5M
0M
0M
304M
0M
0M
-133M
170M
-133M
0M
0M
199M
199M
0M
0M
25M
0M
0M
15M
0M
0M
0M
13M
13M
6M
0M
0M
0M
0M
0M
186M
186M
-118M
0M
0M
183M
183M
0M
0M
0M
0M
0M
18M
0M
0M
0M
268M
8M
3M
0M
0M
260M
0M
0M
-85M
174M
-85M
0M
0M